mankind-pharma-profit-growth
Mankind Pharma’s EBITDA rose 27% to Rs 1,175 crore, while international revenue surged nearly 33% in Q2 FY27
Mankind Pharma’s EBITDA rose 27% to Rs 1,175 crore, while international revenue surged nearly 33% in Q2 FY27